In patients with occult cancer, compared to patients with active known cancer, the impact of paraneoplastic hypercoagulability may be smaller as markers of coagulation (D-dimer) and inflammation (CRP and Hb) tend to be less altered at admission in the first group (20). This evidence concerns the gene GSTM1 and cancer.